substance p (6-11), arg(6)-trp(7,9)-me-phe(8)- has been researched along with Lung Neoplasms in 7 studies
*Lung Neoplasms: Tumors or cancer of the LUNG. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haslett, C; MacKinnon, AC; Rossi, AG; Seckl, M; Sethi, T; Tufail-Hanif, U; Wheatley, M | 1 |
| MacKinnon, A; Sethi, T | 1 |
| Cummings, J; Haslett, C; Jodrell, D; MacKinnon, AC; Sethi, T; Tufail-Hanif, U; Waters, CM | 1 |
| Cummings, J; Jones, DA; Langdon, SP; MacLellan, AJ; Rozengurt, E; Smyth, JF | 1 |
| Rozengurt, E; Seckl, MJ | 1 |
| Langdon, S; Muir, M; Ritchie, A; Rozengurt, E; Sethi, T; Smyth, J | 1 |
| Rozengurt, E; Woll, PJ | 1 |
7 other study(ies) available for substance p (6-11), arg(6)-trp(7,9)-me-phe(8)- and Lung Neoplasms
| Article | Year |
|---|---|
Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies.
Topics: Animals; Antineoplastic Agents; Arginine Vasopressin; Calcium; Carcinoma, Small Cell; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Extracellular Signal-Regulated MAP Kinases; Humans; Lung Neoplasms; Peptide Fragments; Pertussis Toxin; Receptors, Bombesin; Receptors, Vasopressin; Signal Transduction; Substance P; Type C Phospholipases | 2009 |
[D-Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism.
Topics: Apoptosis; Carcinoma, Small Cell; Cell Division; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Peptide Fragments; Precipitin Tests; Substance P; Time Factors; Tumor Cells, Cultured | 2003 |
Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11)-induced growth inhibition.
Topics: Animals; Antineoplastic Agents; Bradykinin; Calcium; Carcinoma, Small Cell; Cell Division; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fibroblasts; Gastrin-Releasing Peptide; Humans; Lung Neoplasms; Mice; Mice, Nude; Peptide Fragments; Rats; Receptors, Bombesin; Receptors, Neuropeptide; Substance P; Transplantation, Heterologous; Tumor Cells, Cultured; Vasopressins | 2003 |
Processing of the neuropeptide growth factor antagonist [Arg6, D-Trp7.9, NmePhe8]-substance P (6-11) by a small cell lung cancer cell line (H69).
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cell Line; Chromatography, High Pressure Liquid; Culture Media; Humans; Lung Neoplasms; Peptide Fragments; Substance P; Time Factors | 1995 |
Effect of tyrphostin combined with a substance P related antagonist on small cell lung cancer cell growth in vitro.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cell Division; Dose-Response Relationship, Drug; Drug Synergism; Humans; Lung Neoplasms; Neoplastic Stem Cells; Nitriles; Peptide Fragments; Protein-Tyrosine Kinases; Signal Transduction; Substance P; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tyrphostins | 1996 |
Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo.
Topics: Animals; Calcium; Carcinoma, Small Cell; Drug Screening Assays, Antitumor; Female; Humans; Lung Neoplasms; Mice; Mice, Nude; Peptide Fragments; Signal Transduction; Substance P; Tumor Cells, Cultured | 1992 |
A neuropeptide antagonist that inhibits the growth of small cell lung cancer in vitro.
Topics: Animals; Bradykinin; Calcium; Carcinoma, Small Cell; Cell Division; Cells, Cultured; DNA, Neoplasm; Drug Screening Assays, Antitumor; Gastrin-Releasing Peptide; Humans; Lung Neoplasms; Mice; Peptide Fragments; Peptides; Recombinant Proteins; Substance P; Tumor Cells, Cultured; Vasopressins | 1990 |